{
  "figure_1": "Cumulative incidence (CI) of acute graft-versus-host disease (aGVHD). CI of II-IV aGVHD and III-IV aGVHD in (A) all patients, (B) AML/MDS and (C) ALL.",
  "figure_2": "The estimated CI of chronic GVHD (cGVHD). CI of cGVHD and moderate-severe cGVHD in (A) all patients, (B) AML/MDS and (C) ALL.",
  "figure_3": "The estimated CI of relapse (CIR). (A) CIR in all patients. (B) CIR between intermediate risk AML/MDS and high risk AML/MDS. (C) CIR between standard risk ALL and high risk ALL.",
  "figure_4": "The estimated CI of non-relapse mortality (NRM). (A) NRM in all patients. (B) NRM between intermediate risk AML/MDS and high risk AML/MDS. (C) NRM between standard risk ALL and high risk ALL.",
  "figure_5": "The estimated probability of overall survival (OS). (A) OS in all patients. (B) OS between intermediate risk AML/MDS and high risk AML/MDS. (C) OS between standard risk ALL and high risk ALL.",
  "figure_6": "The estimated probability of disease free survival (DFS). (A) DFS in all patients. (B) DFS between intermediate risk AML/MDS and high risk AML/MDS. (C) DFS between standard risk ALL and high risk ALL.",
  "figure_7": "The estimated probability of GVHD/Relapse free survival (GRFS). (A) GRFS in all patients. (B) GRFS between intermediate risk AML/MDS and high risk AML/MDS. (C) GRFS between standard risk ALL and high risk ALL."
}